Cancer diagnostics 2017: Scientific program

Oncodiagnostics 2017conferenceseries.com
http://oncodiagnostics.cancersummit.org/
***For available speaker slots***
oncodiagnostics@cancersummit.org
Tentative Program
Interactive
Sessions
Keynote
Lectures
Exhibitors B2B
Meetings
Plenary
Lectures
Workshops
November 27- 28, 2017 Dubai, UAE
International Conference on
Cancer Diagnostics

Invitation...
Dear Colleagues,
Conferenceseries LLC invites all the participants from all over the world to attend
“International Conference on Annual Oncologists Meeting” during November 27-
28, 2017 at Dubai, UAE which includes prompt keynote presentations, Oral talks, Poster
presentations and Exhibitions. Oncologists 2016 is the sequel of the past Oncology
Conferences.
With members from around the world focused on learning about Oncologists; this is your
best opportunity to reach the largest assemblage of participants from the Oncologists
Community, Oncology Society, European Oncology Conferences, American Oncology
Society. Conduct presentations, distribute information, meet with current and potential
scientists, make a splash with new drug developments, and receive name recognition at this
3-day event. World-renowned speakers, the most recent techniques, developments, and the
newest updates in Oncology are hallmarks of this conference.
Conference Series LLC, the host of this conference is comprised of 3000+ Global Events
with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical,
Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field
is organizing conferences all over the globe.A step towards Cancer free World, the theme of
the upcoming Oncologists Meeting directs towards addressing main issues like Prevention,
Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative
techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized
by Conference Series LLC. This Oncologists Meeting will have three days of discussions on
methods and strategies related to management, quality improvement of Cancer as well as
to explore the new ideas and concepts on global scale and the topics include lung cancer,
breast cancer, bone cancer, blood cancer, cervical cancer, colon-rectum cancer, prostate
cancer, thyroid cancer.
Organizing committee Member 2017
Diana Anderson
University of Bradford
UK
Alok De
Kansas City VA Medical Center
USA
Aleksandar Stefanović
Clinic for Obstetrics and
Gynecology Clinical Center of
Serbia
Alvaro Macieira-Coelho
French National Institute of Health
(INSERM), France
Sadir Alrawi
Director of Surgical Oncology
Services of Alzahra Cancer Center
Dubai
Sonya Sergieva
Sofia Cancer Center Sofia
Bulgaria
Mohammad A. Qasaimeh
New York University
UAE
Ozge Akbulut
Sabanci University
Turkey
Mohammed Y. Almaghrabi
Prince Faisal Cancer Centre
Saudi Arabia

Featured Presentations @ Oncodiagnostics 2017
Registrations
Salon V Opening Ceremony
Introduction
Keynote Forum
Title: An Empirical Assay for Assessing Genomic Sensitivity and for Improving Cancer Diagnostics
Diana Anderson, University of Bradford, UK
Title: The Decline of the Incidence of Cancers during Organism Senescence.
Alvaro Macieira-Coelho, French National Institute of Health (INSERM), France
Title: Anti-proliferative, anti-angiogenic and anti-metastatic effect of Emblica officinalis
(Amla) on ovarian cancer cells via microRNA regulated and autophagy mechanisms
Alok De, Kansas City VA Medical Center, USA
Title: Microfluidic platforms for isolating tumor cells from blood samples
Mohammad A. Qasaimeh, New York University, UAE
Title: From Drug Discovery to Experimental and Clinical Applications: An Overview of 40
Years Experience in Photodynamic Therapy of Cancer
Mohamed El-Far, Mansoura University, Egypt
Session Introduction
Featured Presenatations @ Oncodiagnostics 2017
Title: Updates of HIPEC in colorectal carcinomatosis Principals and Review
Sadir Alrawi, Alzahra Cancer Center, UAE
Title: Cancer Treatment in the 20th Century are we close to a cure?
Ali Aldameh, Tawam Hospital UAE
Title: Molecular spectra, frequencies, and distribution patterns of somatic mutations using next
generation sequencing in Arab women with breast cancer
Humaid O Al-Shamsi, The University of Texas, USA
Title: Genetics in Oncology, Liquid Biopsy and Circulating Tumor DNA
Lina Abi Mosleh, Ayass Bioscience Inc., USA
Title: All high risk? Pathologic extracapsular extension in the era of human papillomavirus as-
sociated head/neck cancers
Tarek Dufan, American Hospital Dubai, UAE
Title: Metabolic Signatures of Lung Cancer in Sputum and Exhaled Breath
Naseer Ahmed, University of Manitoba, Canada
Title: Evaluation of nonpalpable breast mass excision and sentinel node biopsy using ra-
dio‑guided occult lesion localization: A single‑stage procedure
Timor Al-Alshee, King Abdulaah Medical City, Saudi Arabia
Title: The decrease of MITF, a crucial melanoma transcription factor does not induce marks of
epithelial-mesenchymal transition, maintains the proliferation and invasivity, but diminish the
differentiation of melanoma cells
Jiri Vachtenheim, Charles University, Czech Republic
Speaker Slots Available

Title: Lung Cancer Screening Indications and consensus Guidelines.
Title: Exploiting nanomaterial-induced selective autophagy for enhanced clearance of intracel-
lular aggregate-prone proteins
Long-ping Wen, University of Science & Technology, China
Title: Non-V600 BRAF mutations define a distinct molecular subtype of metastatic colorectal cancer
Title:Role of imaging in follow up of previously diagnosed and treated breast masses
Eman Oweida, NMC Royal Hospital, UAE
Title: Silicone-based composites as surgical breast models for oncoplasty training
Ozge Akbulut, Sabanci University, Turkey
Title:How to prevent chemotherapy medication errors?
Mahdi Shahriari, Shiraz University of Medical Sciences, Iran
Title: Novel Breast Cancer subtypes identified using multiplex biomarker panel assays.prolif-
eration and invasivity, but diminish the differentiation of melanoma cells.
Godfrey Grech, University of Malta, Malta
Title: Whole body MRI in the detection of skeletal metastasis. Our experience with 3 Tesla
MRIdifferentiation of melanoma cells
Jamal Abdulkarim, University of Warwick, UK
Special session
Title: Updates in Pelvic and Sacral Resections
Mohammed Al Sobeai, The Ottawa Hospital, University of Ottawa, Ottawa, Canada
Title: Preliminary results of continuation maintenance treatment with pemetrexedin advanced
non-squamous non small cell lung cancer(NSCLC) patients after prior induction chemothera-
py– Single-Arm Phase II Study
Nesreen Mohamed, Tanta university Hospital, Egypt
Introduction
Title: Role of SPECT-CT imaging techniques in oncology
Sonya Sergieva, Sofia Cancer Center Sofia, Bulgaria
Title:Micro RNA (miRNA): Utility in oncology
Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia
Title: The design and properties of synthetic tissue/organ models
Title: Fertility sparing surgery in early stages of cervical cancer
Aleksandar Stefanović, Clinical Center of Serbia, Serbia
Title: Urachal Carcinoma: multimodality treatment outcome, the MD Anderson experience, A
retrospective study

Title: Upper Gastrointestinal Surgery: National management trends and outcomes.
Title: Fertility sparing approach in young patients with early stages of endometrial cancer
Katarina Jeremic, University of Belgrade, Serbia
Title: Regulation of LncRNA-MIF in c-Myc homeostasis
Mian Wu, University of Science and Technology of China, China
Title: Religion/spiritual beliefs and oncology team who care for cancer patients
Title: Silicone-based composites as surgical breast models for oncoplasty training
Title: From bench to bed: Impact of vitamin D3 replacement therapy on clinical outcomes and
survival rates in cancer patients
Title: Effects Of Natural Pigments On The Poly ( methyl methacrylate ) Biopolymer
Jaleel Kareem Ahmed, Babylon University, Iraq
Title: Hip Arthroplasty in Metastatic Bone Disease of the Hip-Tertiary care center experience
Giant Femoral Intra-Cortical Schwannoma - Case Report and Review of the Literature
Title: A study regarding the dermocosmetic care of cutaneous side-effects associated with che-
motherapy between breast cancer patients
Athanasia Varvaresou, Technological Educational Institute of Athens, Greece
Title: Functional assessment of quality of life using EORTC QLQ-CR29 in patients with colon
cancer at King Abdulaziz University Hospital
Ssakher M Al Otaibi, King Abdullah Medical City, Saudi Arabia
Abdullah Almoshadq, King Abdullah Medical City, Saudi Arabia
Title: Assessment of the level of knowledge about breast cancer related symptoms and treatment
Salma Abdullah Jabarty, King Khalid University
KSA, Raghad Hamed Almusfir, King Khalid University, KSA
Title: Dermocosmetic treatment for radiodermatitis in oncology patients
Varvaresou A, Technological Educational Institute of Athens, Greece
Title: Cytogenetic analysis in 101 Tunisian patients with de novo acute myeloid leukemia.
Hend Chaker, Pasteur Institute of Tunis, Tunisia
Title: CA125 and histological type of ovary cancer
Toufik Attouche, Pierre & Marie Curie Center, Algeria
Title: Epidemiologic patterns of breast cancer in Northern Saudi Arabia
Ali Ghannam Alrashdi, University of Hail, Saudi Arabia

Conference Highlights
• Oncology
• Clinical Oncology
• Pediatric Oncology
• Radiation Oncology
• Hematology Oncology
• Chemotherapy
• Oncologists
• Organ Specific Cancer
• Cancer : Causes
• Cancer: Diagnostics and
Staging
• Cancer: Treatment and
Therapy
• Cancer Biomarkers
• Cancer and Pharmacology
• Cancer Diagnostics Market
• Cancer Diagnostics - Types
and staging
• Types of Oncology
• Cancer Screening Tests
• Cancer Biomarkers
• Cancer & Tumour
Immunology
• Cancer and Pharmacology
• Cancer : Vaccines and
Prevention
• Cancer and Alternative
Medicine
For detailed sessions, please visit: http://oncodiagnostics.cancersummit.org/
Submit your abstract online at: http://oncodiagnostics.cancersummit.org//abstract-submission.php
Register online: http://oncodiagnostics.cancersummit.org//registration.php

Oncodiagnostics 2017
conferenceseries.com
Organizing Committee Members: 2016-17
Diana Anderson
University of Bradford
UK
Alvaro Macieira-Coelho
French National Institute of Health
(INSERM), France
Abdolrahman Shams Nateri
University of Nottingham
UK
Seema Singh
Mitchell Cancer Institute
USA
Jose J. Jimenez-Moleon
University of Granada
Spain
Rudolf Scheissel
Österreichische Gesellschaft für
Chirurgie, Austria
Ferdinando Agresta
ULSS19 del Veneto Adria (RO)
Italy
Alireza Heidari
California South University
USA
Alok De
Kansas City VA Medical Center
USA
Jiri Vachtenheim
Charles University
Czech Republic
Aleksandra Czerw
Medical University of Warsaw
Poland
Ajay Singh
Mitchell Cancer Institute
USA
Eckhard Nagel
University of Beyruth
Germany

Oncologists 2016 Testmonials
Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia
It was highly informative meeting. I was surprised with such organization and arrangement. I met some
figures who had inspired me. I came across with a dozen of ideas that can easily implement in clinical
research.
Diana Anderson, University of Bradford, UK
It was a good conference and all the speakers gave very clear presentations.I think this is very worth
full conference.
Sonya Sergieva, Sofia Cancer Center Sofia, Bulgaria
The conference was organized perfectly. I would like to thank organiser for excellent hotel,congress
programme, certificate, materials. Thank you for the warm hospitality.
Jaleel Kareem Ahmed, Babylon University, Iraq
The conference was well arranged , good place , good time , good interval , excellent articles by profes-
sional researchers.
Dr. Alvaro Macieira-Coelho, French National Institute of Health
(INSERM), France
Dr. Alok De, Kansas City VA Medical Center, USA
Dr. Ali Aldameh, Al Zahra cancer centre, UAE
Dr. Humaid O Al-Shamsi, The University of Texas, USA
Dr. Tarek Dufan, American Hospital Dubai, UAE
Dr. Diana Anderson, University of Bradford, UK
Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
Dr. Martin Kristensson, Visiopharm, Denmark
Glimpsesof16th
GlobalAnnualOncologistsMeeting
The success of the Oncologists 2017 conference has given us the
prospect to bring the gathering one more time. Conferenceseries
LLC hosted the “16th
Global Annual Oncologists Meeting” during
April 24-25, 2016 at JW Marriott Dubai, UAE
Theconferencewasembarkedwithanopeningceremonyfollowed
by Keynote sessions and followed by series of lectures delivered by
both Honorable Guests and members of the Keynote forum. The
adepts who promulgated the theme with their exquisite talk were:

Glimpses of Oncologists 2016

Why to Attend???
• Present your research, transfer your capability, hear case studies and improve practical information to
ensure success in cancer management.
• Participate in workshops led by an experts
• Expand your network for clinical support, collaboration and education
• Keep up to date and make empowered and educated decisions on what is happening in the field of cancer
• Access more than twenty hours of networking with cancer professionals from different countries across
all fields.
Abstract Information: Oral / Poster Presentation Guidelines
Oral Presentations are generally split into TWO categories, as follows:
1. Plenary Lectures
Each Plenary lecture is 25 minutes 20 minutes for talks and 5 minutes for Questions/discussion, where these
are presented as debates as well based on the two speakers decision. Speakers should communicate in advance
of the Moderator so that presentations may be coordinated.
2. Oral Sessions
Each Oral Session is 60 minutes in length and comprises two presentations, of 30 minutes each.
Please prepare you presentation in 16:9 format (screen are in format 16:9). We recommend saving in PowerPoint
presentation using PPT(X) format instead of PPS.
3. Speaker Preview Room
All speakers are asked to upload their presentation at the Speaker Preview Room (located in the Registration
area) at least one hour before the beginning of the session or the day before in case of a morning session.

Day 1: November 27, 2017
Opening Ceremony
Conference Souvenir Launch
New Perspective frontiers in the area of Biologics and
Biosimilars
Keynote Forum (& Exhibitions Full day)
(Panel discussions and Reviews)
Coffee Break: Networking & Refreshments
Group Photo
Speaker Forum
Sessions Chair’s Introduction
Cancer Diagnostics Market
Cancer Diagnostics - Types and staging
Types of Oncology | Pediatric Oncology
Organ Specific Cancer | Cancer Biopsy
Cancer Screening Tests
Panel discussions and Reviews
Lunch Break
Young Research Forum
B2B Meetings
Certificates Felicitation by the organizing Committee
Speaker Forum
Cancer: Treatment and Therapy
Cancer and Pharmacology
Cancer : Vaccines and Prevention
Cancer and Alternative Medicine
Oncology Case reports
Speaker Sessions (Cont…)
Poster Sessions Evaluation by the Committee
Refreshments
Award Ceremony
Felicitation of the best poster awards
Closing Ceremony
Day 2: November 28, 2017
Introduction
Keynote Forum (& Exhibitions Full day)
Speaker Forum
Cancer Biomarkers
Cancer & Tumour Immunology
Oncology | Comprehensive Geriatric Oncology
Chemotherapy
Cancer : Causes | Cancer Pharma Industry
Lunch Break
B2B Meetings
Certificates Felicitation by the organizing Committee
Program

Plan your Trip to Dubai
Burj al arab Burj-Khalifa
Burj-Khalifa-Lake Deira-Clocktower
wild-wadi-
Mall-Of-The-Emirates Palm-Jumeirah-At-Night
Bastakia

About Dubai
Dubai has emerged as a global city and business hub of the Middle East. Dubai was ranked 44th among
the world’s best financial cities and the world’s 27th richest city in 2012. It is also an international financial
centre and has been ranked 37th within the top 50 global financial cities and 1st within the Middle East.
The city of Dubai is located on the emirate’s northern coastline and heads up the Dubai-Sharjah-Ajman
metropolitan area. The emirate of Dubai shares borders with Abu Dhabi in the south, Sharjah in the
northeast, and the Sultanate of Oman in the southeast.
Cancer, which is now the third leading cause of death in the UAE (after cardiovascular disease and
injury) causing 10% of all deaths in 2010 and 16% of all deaths in the emirate of Abu Dhabi during the
same year. The incidence of all cancers is projected to double by 2020, primarily due to ageing and also
possibly due to increased exposure to risk factors for cancer. Approximately 12.7 million cancer cases and
7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the
deaths occurred in the economically developing world.
Theme : “Joining hands towards cancer awareness”
VENUE DETAILS
Jw Marriott Dubai
Abu Baker Al siddique Road, Hamarain Centre Deira
Po Box 16590, Dubai, UAE, fax: +971 4 607 7774

Dubai is known as second largest emirate in UAE which
occupies an area of 3,885kms. Dubai is known as Muslim city,
where tradition plays an important role. Dubai’s fascinating
history and vibrant heritage offers its visitors a glimpse into
its culture. It is one of the biggest business hubs in the world.
It is well known for its warm hospitality and rich cultural
heritage. Most of the Dubai’s tourist attractions include The
Dubai mall, Burj Khalifa, Dubai world trade centre and Dubai
marina. Dubai mall is the world’s largest shopping centre with
1,200 stores in it. Hence some of these facts make Dubai an
interesting place for tourism and business events.
History of Dubai:
800 members approximately of the Bani Yas tribe, led by the
Maktoum family were settled at the mouth of the creek in
1833.As the creek a natural harbour ,Dubai soon became a
center for fishing, pearl and sea trade. By 20th century Dubai
became a successful port. Oil was discovered in 1966; Sheikh
Rashid utilized the oil for revenues to spur the infrastructure
development in Dubai.
You’ll fall in love with Dubai
Venue:
JW Marriott Dubai Abu Baker Al Siddique
Road, Hamarain Centre| Deira | PO Box 16590
| Dubai | U.A.E. | Tel: +971 4 607 7764 Fax:
+971 4 607 7774
Venue

Cancer diagnostics 2017: Scientific program

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Cancer diagnostics 2017: Scientific program

Similar to Cancer diagnostics 2017: Scientific program (20)

Recently uploaded

Recently uploaded (20)

Cancer diagnostics 2017: Scientific program